These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15201386)

  • 1. Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment.
    Dionisiotis J; Zoukos Y; Thomaides T
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1079. PubMed ID: 15201386
    [No Abstract]   [Full Text] [Related]  

  • 2. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.
    Blake G; Murphy S
    Neurology; 1997 Dec; 49(6):1747-8. PubMed ID: 9409387
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythema elevatum et diutinum, multiple sclerosis and interferon beta.
    Gil M; Chizzolini C; Kaya G; Hauser C
    Dermatology; 2004; 209(1):75-6. PubMed ID: 15237277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Subacute cutaneous lupus erythematosus and interferon beta-1 a].
    Schmutz J; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Feb; 127(2):237. PubMed ID: 10739993
    [No Abstract]   [Full Text] [Related]  

  • 5. Local reactions after subcutaneous injections of beta-interferon.
    van Rengen A; Goossens A
    Contact Dermatitis; 1998 Oct; 39(4):209. PubMed ID: 9817241
    [No Abstract]   [Full Text] [Related]  

  • 6. Local pain during REBIF injection is not due to acidic pH.
    Buttmann M; Goebeler M; Rieckmann P
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1078. PubMed ID: 15201384
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
    Kocer B; Nazliel B; Oztas M; Batur HZ
    Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L; Neves M; Cardoso E; Melo A
    J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed drug eruption with interferon-beta-1b.
    Tai YJ; Tam M
    Australas J Dermatol; 2005 Aug; 46(3):154-7. PubMed ID: 16008645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation of psoriasis in patients undergoing treatment with interferon-beta].
    Navne JE; Hedegaard U; Bygum A
    Ugeskr Laeger; 2005 Aug; 167(32):2903-4. PubMed ID: 16109199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
    Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
    Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrotizing cutaneous lesions caused by interferon beta injections in a patient with multiple sclerosis.
    Feldmann R; Löw-Weiser H; Duschet P; Gschnait F
    Dermatology; 1997; 195(1):52-3. PubMed ID: 9267740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon-β1b in multiple sclerosis therapy: more than 20 years clinical experience].
    Hartung HP; Haas J; Meergans M; Tracik F; Ortler S
    Nervenarzt; 2013 Jun; 84(6):679-704. PubMed ID: 23669866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
    Duchini A
    Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon beta retinopathy in a patient with multiple sclerosis.
    Post JW; Colleaux K
    Can J Ophthalmol; 2009 Oct; 44(5):e37. PubMed ID: 19798812
    [No Abstract]   [Full Text] [Related]  

  • 17. An open labelled assessment of adverse effects associated with interferon 1-beta in the treatment of multiple sclerosis.
    Ozuma J
    J Neurosci Nurs; 1996 Apr; 28(2):72. PubMed ID: 8718753
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis.
    Pulicken M; Bash CN; Costello K; Said A; Cuffari C; Wilterdink JL; Rogg JM; Mills P; Calabresi PA
    Mult Scler; 2005 Apr; 11(2):169-74. PubMed ID: 15794390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.
    Christopher V; Scolding N; Przemioslo RT
    J Neurol; 2005 Jul; 252(7):855-6. PubMed ID: 15742101
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS.
    Pöllmann W; Erasmus LP; Feneberg W; Then Bergh F; Straube A
    Neurology; 2002 Aug; 59(4):636-9. PubMed ID: 12196668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.